TiumBio Company Description

TiumBio Co., Ltd., a drug discovery company, researches and develops therapeutics for patients with unaddressed rare diseases.

The company’s products pipeline includes chemical entity-based drugs and biopharmaceuticals comprising NCE401, NCE403, NCE406, NCE604, NCE611, and NBP.

It has a collaboration agreement with Oncodesign Société Anonyme for the research and development of fibrosis drug candidates.

TiumBio Co., Ltd. was founded in 2016 and is based in Seongnam-si, South Korea.

TiumBio Co., Ltd.

Country	South Korea
Founded	2016
Industry	Biological Products, Except Diagnostic Substances
CEO	Huntaek Kim

Contact Details

Address: 49, Daewangpangyo-ro 644beon-gil Seongnam-si, 13493 South Korea
Phone	82 3 1600 1500

Stock Details

Ticker Symbol	321550
Exchange	KOSDAQ
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	KRW
SIC Code	2836

Key Executives

Name	Position
Huntaek Kim	Chief Executive Officer
Hyunsil Koh	Chief Financial Officer